HIGHLIGHTS
- who: NA receptors and collaborators from the Central Institute of Mental Health, Mannheim Faculty, Heidelberg University, Mannheim, Germany (Dr have published the article: Region-Specific Enhancement of c-fos Expression by Combined Treatment With NMDA Receptor Agonists and Antagonists With Antidepressant Potential, in the Journal: (JOURNAL)
- what: The authors aimed to evaluate the network effects of rapastinel, focusing on brain regions involved in depression and psychosis.
SUMMARY
Rapastinel is a novel N-methyl-D-aspartate-receptor (NMDAR) modulator that enhances NMDAR function and displays fast antidepressant and antipsychotic actions without the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.